Maha Mamdouh Osman, Amany Ibrahim Mustafa, Karim Reda Karim, Fatma Mohamed Mohamed Elesawy
{"title":"解偶联蛋白 2 和 Dynamin 相关蛋白 1 mRNA 基因表达可能是白癜风活动性和严重程度的关键标志物","authors":"Maha Mamdouh Osman, Amany Ibrahim Mustafa, Karim Reda Karim, Fatma Mohamed Mohamed Elesawy","doi":"10.21608/bmfj.2024.273744.2029","DOIUrl":null,"url":null,"abstract":": Background: Vitiligo is a depigmenting skin condition due to the attenuation of melanin in the affected skin area due to specific melanocyte loss. The pathophysiology of vitiligo has been linked to both mitochondrial malfunction and oxidative stress. Dynamin-related protein 1 (DRP1) is a regulator of mitochondrial fission. Uncoupling Protein 2 (UCP2) is an essential mitochondrial protein that regulates cellular energy metabolism. Objectives: This study aimed to assess the gene expression levels of UCP2 and DRP1 in vitiligo patients and correlate those levels with the activity and severity of the disease. Methods: This case-control study included 40 vitiligo patients and 40 age and sex matched healthy controls. Gene expression levels of UCP2 and Drp1 were measured using an enzyme-linked immunosorbent assay. Results: The vitiligo group had significantly higher serum UCP2 and Drp1 gene expression levels (p<0.001 for each) When compared to the control group. UCP2 gene expression showed a significant negative correlation with VIDA score (p<0.001). Drp1 gene expression showed significant negative correlations with age and duration of vitiligo (p=0.002, 0.001 respectively) and a positive correlation with VIDA score (p<0.001). Conclusions: The findings suggest the potential role of dysregulation of Drp1 and UCP2 gene expression in vitiligo. For patients with vitiligo, both markers showed prognostic and diagnostic values.","PeriodicalId":503219,"journal":{"name":"Benha Medical Journal","volume":" 46","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Uncoupling Protein 2 and Dynamin-related Protein1 mRNA Gene Expression as possible key Markers of activity and severity of Vitiligo\",\"authors\":\"Maha Mamdouh Osman, Amany Ibrahim Mustafa, Karim Reda Karim, Fatma Mohamed Mohamed Elesawy\",\"doi\":\"10.21608/bmfj.2024.273744.2029\",\"DOIUrl\":null,\"url\":null,\"abstract\":\": Background: Vitiligo is a depigmenting skin condition due to the attenuation of melanin in the affected skin area due to specific melanocyte loss. The pathophysiology of vitiligo has been linked to both mitochondrial malfunction and oxidative stress. Dynamin-related protein 1 (DRP1) is a regulator of mitochondrial fission. Uncoupling Protein 2 (UCP2) is an essential mitochondrial protein that regulates cellular energy metabolism. Objectives: This study aimed to assess the gene expression levels of UCP2 and DRP1 in vitiligo patients and correlate those levels with the activity and severity of the disease. Methods: This case-control study included 40 vitiligo patients and 40 age and sex matched healthy controls. Gene expression levels of UCP2 and Drp1 were measured using an enzyme-linked immunosorbent assay. Results: The vitiligo group had significantly higher serum UCP2 and Drp1 gene expression levels (p<0.001 for each) When compared to the control group. UCP2 gene expression showed a significant negative correlation with VIDA score (p<0.001). Drp1 gene expression showed significant negative correlations with age and duration of vitiligo (p=0.002, 0.001 respectively) and a positive correlation with VIDA score (p<0.001). Conclusions: The findings suggest the potential role of dysregulation of Drp1 and UCP2 gene expression in vitiligo. For patients with vitiligo, both markers showed prognostic and diagnostic values.\",\"PeriodicalId\":503219,\"journal\":{\"name\":\"Benha Medical Journal\",\"volume\":\" 46\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-07-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Benha Medical Journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.21608/bmfj.2024.273744.2029\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Benha Medical Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21608/bmfj.2024.273744.2029","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
:背景:白癜风是一种脱色性皮肤病,由于特定的黑色素细胞脱失导致患处皮肤黑色素减少。白癜风的病理生理学与线粒体功能失调和氧化应激有关。Dynamin-related protein 1(DRP1)是线粒体裂变的调节剂。解偶联蛋白2(UCP2)是一种重要的线粒体蛋白,可调节细胞能量代谢。研究目的本研究旨在评估白癜风患者体内 UCP2 和 DRP1 的基因表达水平,并将这些水平与疾病的活动性和严重程度相关联。方法:本病例对照研究纳入了 40 名白癜风患者:这项病例对照研究包括 40 名白癜风患者和 40 名年龄和性别匹配的健康对照者。采用酶联免疫吸附试验测定了 UCP2 和 Drp1 的基因表达水平。结果显示与对照组相比,白癜风组的血清 UCP2 和 Drp1 基因表达水平明显更高(P<0.001)。UCP2 基因表达与 VIDA 评分呈显著负相关(p<0.001)。Drp1 基因表达与年龄和白癜风病程呈显著负相关(分别为 p=0.002 和 0.001),与 VIDA 评分呈正相关(p<0.001)。结论研究结果表明,Drp1和UCP2基因表达失调在白癜风中具有潜在作用。对于白癜风患者来说,这两个标记物具有预后和诊断价值。
Uncoupling Protein 2 and Dynamin-related Protein1 mRNA Gene Expression as possible key Markers of activity and severity of Vitiligo
: Background: Vitiligo is a depigmenting skin condition due to the attenuation of melanin in the affected skin area due to specific melanocyte loss. The pathophysiology of vitiligo has been linked to both mitochondrial malfunction and oxidative stress. Dynamin-related protein 1 (DRP1) is a regulator of mitochondrial fission. Uncoupling Protein 2 (UCP2) is an essential mitochondrial protein that regulates cellular energy metabolism. Objectives: This study aimed to assess the gene expression levels of UCP2 and DRP1 in vitiligo patients and correlate those levels with the activity and severity of the disease. Methods: This case-control study included 40 vitiligo patients and 40 age and sex matched healthy controls. Gene expression levels of UCP2 and Drp1 were measured using an enzyme-linked immunosorbent assay. Results: The vitiligo group had significantly higher serum UCP2 and Drp1 gene expression levels (p<0.001 for each) When compared to the control group. UCP2 gene expression showed a significant negative correlation with VIDA score (p<0.001). Drp1 gene expression showed significant negative correlations with age and duration of vitiligo (p=0.002, 0.001 respectively) and a positive correlation with VIDA score (p<0.001). Conclusions: The findings suggest the potential role of dysregulation of Drp1 and UCP2 gene expression in vitiligo. For patients with vitiligo, both markers showed prognostic and diagnostic values.